Auto Ancillary · Founded 1986 · www.bharatseats.com · BSE 523229 · NSE BHARAT SEATS · ISIN INE415D01024
No Notes Added Yet
Business
Bharat Seats Ltd. is an Indian auto ancillary company primarily engaged in the manufacturing of automotive seating systems and components. The company supplies complete seat assemblies, seat frames, and other related parts for passenger vehicles. Its core business model involves acting as an original equipment manufacturer (OEM) supplier, collaborating with leading automakers to design, develop, and produce seats that meet their specific requirements. The company generates revenue through the sale of these seating systems and components directly to vehicle manufacturers.
Revenue Mix
The primary business segment for Bharat Seats Ltd. is the manufacturing and supply of automotive seating systems and components. While detailed revenue mix by specific product type (e.g., complete seats vs. frames) is not readily available in public domain without deep dive into financial reports, the overwhelming majority of its revenue is derived from its OEM supply chain activities within the automotive sector, focusing on passenger cars.
Industry
Bharat Seats operates in the Indian auto ancillary industry, specifically within the automotive seating segment. This industry is characterized by high capital intensity, technological sophistication, and strong relationships with OEMs. The market is competitive, with a mix of global players and domestic manufacturers. Bharat Seats holds a significant position as a long-standing supplier to Maruti Suzuki India Ltd., a dominant player in the Indian passenger vehicle market, and also supplies to Honda Cars India. This strategic association with major OEMs provides it with a stable revenue base and leverages the growth of these vehicle manufacturers.
MOAT
Bharat Seats possesses several competitive advantages:
Established OEM Relationships: Decades-long partnerships with major automotive OEMs like Maruti Suzuki and Honda, which create high switching costs due to integration into product development cycles, quality approvals, and supply chain reliability.
Technical Expertise & R&D: Capability to co-design and develop seating systems tailored to specific vehicle platforms, ensuring compliance with safety standards and comfort requirements.
Scale & Operational Efficiency: As a large-scale supplier, it benefits from economies of scale in manufacturing and procurement, which can lead to cost efficiencies.
Growth Drivers
Growth in Indian Passenger Vehicle Market: Overall expansion of the Indian passenger car market, driven by rising disposable incomes, urbanization, and improving infrastructure.
Increased Content Per Vehicle: Potential for higher value-added seating solutions (e.g., premium upholstery, advanced adjustability, safety features) driving higher revenue per vehicle.
New Model Launches by OEM Customers: Introduction of new car models by key OEM clients (Maruti Suzuki, Honda) requiring fresh tooling and supply contracts for seating systems.
Expansion with Existing & New OEMs: Deepening relationships with current clients and potentially onboarding new OEM customers or expanding into new vehicle segments.
Risks
Cyclicality of Auto Industry: The company's performance is directly tied to the highly cyclical nature of the automotive industry, making it vulnerable to economic downturns and fluctuations in vehicle sales.
Reliance on Key Customers: A significant portion of revenue is derived from a few large OEM customers (e.g., Maruti Suzuki), making the company susceptible to their production volumes, market share, and purchasing decisions.
Raw Material Price Volatility: Exposure to fluctuations in prices of key raw materials like steel, fabric, foam, and polymers, which can impact manufacturing costs and margins.
Technological Disruption: Evolving trends in vehicle interiors, lightweighting, electric vehicles, and autonomous driving could necessitate significant R&D investments and adaptation.
Intense Competition: Competition from both domestic and international auto ancillary players can put pressure on pricing and market share.
Management & Ownership
Bharat Seats Ltd. is promoted by the Relan Group. The company has a professional management team with experience in the automotive industry. The promoter group holds a significant stake in the company, aligning their interests with long-term growth. Ownership structure typically includes the promoter group, institutional investors, and public shareholders. The close association with Suzuki Motor Corporation (through a joint venture in a related company, Maruti Suzuki India Limited) also signifies strong corporate backing and governance standards related to such partnerships.
Outlook
Bharat Seats Ltd. benefits from its entrenched position as a key supplier to major Indian passenger vehicle OEMs, particularly Maruti Suzuki. The strong long-term relationships and technical capabilities provide a stable foundation. The company's future performance will largely hinge on the growth trajectory of the Indian automotive market, especially the passenger vehicle segment, and the success of new model launches by its primary customers. While the cyclicality of the auto industry and dependence on key clients present inherent risks, the company's established presence and focus on essential vehicle components position it to capitalize on market recovery and expansion. Continuous investment in technology and manufacturing efficiency will be crucial to mitigate competitive pressures and adapt to evolving industry trends.
Price goes above X
Price falls below X
PE goes above X
PE falls below X
| #(Fig in Cr.) | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Net Sales | 278 | 299 | 291 | 306 | 393 | 427 | 459 | 491 | 574 | 578 |
| Other Income | 1 | 1 | 1 | 1 | 1 | 1 | 3 | 1 | 1 | 1 |
| Total Income | 279 | 300 | 291 | 307 | 394 | 428 | 461 | 492 | 575 | 579 |
| Total Expenditure | 261 | 282 | 273 | 288 | 370 | 405 | 436 | 466 | 545 | 550 |
| Operating Profit | 18 | 17 | 18 | 19 | 24 | 23 | 25 | 26 | 30 | 29 |
| Interest | 2 | 2 | 2 | 2 | 2 | 3 | 3 | 2 | 2 | 2 |
| Depreciation | 6 | 6 | 6 | 7 | 7 | 8 | 9 | 9 | 9 | 9 |
| Exceptional Income / Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -1 | 0 | 0 |
| Profit Before Tax | 11 | 9 | 10 | 10 | 15 | 12 | 13 | 13 | 19 | 18 |
| Provision for Tax | 2 | 2 | 2 | 3 | 4 | 3 | 3 | 4 | 5 | 5 |
| Profit After Tax | 8 | 7 | 7 | 8 | 11 | 9 | 10 | 10 | 13 | 13 |
| Adjustments | 0 | 0 | 0 | 0 | -0 | 0 | 0 | -0 | 0 | 0 |
| Profit After Adjustments | 8 | 7 | 7 | 8 | 11 | 9 | 10 | 10 | 13 | 13 |
| Adjusted Earnings Per Share | 1.3 | 1.1 | 1.1 | 1.2 | 1.8 | 1.5 | 1.6 | 1.6 | 2.1 | 2.1 |
| #(Fig in Cr.) | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Sales | 700 | 840 | 970 | 904 | 589 | 548 | 818 | 1051 | 1067 | 1289 | 1951 | 2102 |
| Other Income | 2 | 1 | 1 | 5 | 2 | 2 | 5 | 4 | 5 | 4 | 5 | 6 |
| Total Income | 702 | 842 | 971 | 909 | 591 | 550 | 823 | 1055 | 1071 | 1292 | 1956 | 2107 |
| Total Expenditure | 670 | 803 | 906 | 854 | 553 | 521 | 785 | 1005 | 1006 | 1213 | 1852 | 1997 |
| Operating Profit | 32 | 38 | 66 | 55 | 38 | 29 | 37 | 50 | 65 | 79 | 104 | 110 |
| Interest | 5 | 4 | 3 | 3 | 3 | 4 | 4 | 4 | 8 | 9 | 10 | 9 |
| Depreciation | 17 | 17 | 19 | 21 | 22 | 18 | 18 | 17 | 24 | 26 | 35 | 36 |
| Exceptional Income / Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -1 | -1 |
| Profit Before Tax | 10 | 17 | 44 | 31 | 12 | 7 | 16 | 30 | 34 | 44 | 58 | 63 |
| Provision for Tax | 3 | 5 | 15 | 10 | -0 | 2 | 4 | 8 | 9 | 11 | 15 | 17 |
| Profit After Tax | 7 | 12 | 28 | 21 | 13 | 5 | 12 | 22 | 25 | 33 | 42 | 46 |
| Adjustments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit After Adjustments | 7 | 12 | 28 | 21 | 13 | 5 | 12 | 22 | 25 | 33 | 42 | 46 |
| Adjusted Earnings Per Share | 1.1 | 1.9 | 4.5 | 3.4 | 2 | 0.8 | 1.9 | 3.4 | 4 | 5.2 | 6.7 | 7.4 |
| # | 1 Year | 3 Year | 5 Year | 10 Year |
|---|---|---|---|---|
| Sales CAGR | 51% | 23% | 29% | 11% |
| Operating Profit CAGR | 32% | 28% | 29% | 13% |
| PAT CAGR | 27% | 24% | 53% | 20% |
| # | 1 Year | 3 Year | 5 Year | 10 Year |
|---|---|---|---|---|
| Share Price CAGR | 10% | 49% | 39% | 23% |
| ROE Average | 20% | 18% | 16% | 17% |
| ROCE Average | 24% | 21% | 19% | 19% |
| #(Fig in Cr.) | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Shareholder's Funds | 53 | 62 | 87 | 105 | 113 | 117 | 127 | 146 | 167 | 195 | 230 |
| Minority's Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Borrowings | 22 | 20 | 22 | 20 | 24 | 25 | 33 | 33 | 53 | 50 | 38 |
| Other Non-Current Liabilities | 10 | 8 | 14 | 15 | 16 | 9 | 9 | 12 | 72 | 74 | 64 |
| Total Current Liabilities | 167 | 175 | 162 | 133 | 89 | 141 | 169 | 167 | 213 | 329 | 406 |
| Total Liabilities | 252 | 265 | 285 | 273 | 242 | 291 | 337 | 358 | 505 | 648 | 737 |
| Fixed Assets | 144 | 146 | 136 | 152 | 150 | 126 | 147 | 199 | 276 | 283 | 356 |
| Other Non-Current Assets | 5 | 2 | 19 | 7 | 30 | 43 | 16 | 27 | 67 | 102 | 25 |
| Total Current Assets | 103 | 117 | 130 | 114 | 62 | 122 | 174 | 132 | 163 | 263 | 356 |
| Total Assets | 252 | 265 | 285 | 273 | 242 | 291 | 337 | 358 | 505 | 648 | 737 |
| #(Fig in Cr.) | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Opening Cash & Cash Equivalents | 1 | 0 | 0 | 2 | 10 | 1 | 1 | 0 | 0 | 0 | 3 |
| Cash Flow from Operating Activities | 34 | 38 | 69 | 35 | 28 | 19 | 16 | 43 | 57 | 96 | 107 |
| Cash Flow from Investing Activities | -6 | -17 | -23 | -24 | -34 | -12 | -15 | -59 | -73 | -68 | -47 |
| Cash Flow from Financing Activities | -28 | -22 | -44 | -4 | -3 | -7 | -2 | 17 | 16 | -25 | -47 |
| Net Cash Inflow / Outflow | 0 | 0 | 2 | 7 | -9 | -0 | -1 | 0 | -0 | 3 | 12 |
| Closing Cash & Cash Equivalent | 1 | 0 | 2 | 10 | 1 | 1 | 0 | 0 | 0 | 3 | 15 |
| # | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Earnings Per Share (Rs) | 1.15 | 1.94 | 4.49 | 3.41 | 1.99 | 0.77 | 1.9 | 3.43 | 3.99 | 5.21 | 6.72 |
| CEPS(Rs) | 3.78 | 4.66 | 7.54 | 6.69 | 5.57 | 3.63 | 4.7 | 6.15 | 7.81 | 9.39 | 12.34 |
| DPS(Rs) | 0.45 | 0.45 | 0.5 | 0.5 | 0.25 | 0.25 | 0.4 | 0.7 | 0.8 | 1.1 | 1.5 |
| Book NAV/Share(Rs) | 8.51 | 9.89 | 13.82 | 16.65 | 18.04 | 18.57 | 20.24 | 23.3 | 26.56 | 30.98 | 36.57 |
| Core EBITDA Margin(%) | 3.73 | 3.89 | 6.45 | 5.49 | 6.08 | 4.9 | 3.93 | 4.4 | 5.7 | 5.85 | 5.08 |
| EBIT Margin(%) | 1.92 | 2.25 | 4.66 | 3.79 | 2.62 | 1.99 | 2.42 | 3.16 | 3.87 | 4.1 | 3.47 |
| Pre Tax Margin(%) | 1.24 | 1.77 | 4.34 | 3.45 | 2.08 | 1.21 | 1.95 | 2.82 | 3.15 | 3.41 | 2.95 |
| PAT Margin (%) | 0.91 | 1.28 | 2.82 | 2.37 | 2.13 | 0.88 | 1.46 | 2.05 | 2.35 | 2.54 | 2.16 |
| Cash Profit Margin (%) | 2.99 | 3.09 | 4.72 | 4.65 | 5.94 | 4.16 | 3.61 | 3.67 | 4.6 | 4.57 | 3.97 |
| ROA(%) | 2.78 | 4.71 | 10.27 | 7.69 | 4.87 | 1.8 | 3.79 | 6.2 | 5.81 | 5.67 | 6.1 |
| ROE(%) | 14.47 | 21.06 | 37.9 | 22.39 | 11.49 | 4.18 | 9.77 | 15.76 | 16 | 18.1 | 19.91 |
| ROCE(%) | 11.43 | 16.81 | 39.42 | 27.92 | 11.02 | 7.35 | 12.61 | 17.95 | 17.91 | 19.94 | 24.45 |
| Receivable days | 36.72 | 34.08 | 34.24 | 34.64 | 35.31 | 39.55 | 43.14 | 35.98 | 34.17 | 42.46 | 43 |
| Inventory Days | 5.98 | 5.74 | 7.79 | 9.95 | 13.16 | 16.75 | 18.45 | 14.21 | 11.73 | 13.47 | 10.81 |
| Payable days | 57.58 | 55.33 | 60.45 | 65.96 | 76.33 | 79.15 | 65.64 | 50.31 | 53.66 | 67.73 | 62.7 |
| PER(x) | 15.71 | 18.43 | 19.1 | 13.37 | 8.88 | 40.41 | 17.59 | 11.83 | 17.98 | 14.75 | 21 |
| Price/Book(x) | 2.12 | 3.61 | 6.21 | 2.74 | 0.98 | 1.67 | 1.65 | 1.74 | 2.7 | 2.48 | 3.86 |
| Dividend Yield(%) | 2.49 | 1.26 | 0.58 | 1.1 | 1.41 | 0.81 | 1.2 | 1.72 | 1.12 | 1.43 | 1.06 |
| EV/Net Sales(x) | 0.27 | 0.34 | 0.58 | 0.34 | 0.24 | 0.41 | 0.3 | 0.3 | 0.5 | 0.43 | 0.47 |
| EV/Core EBITDA(x) | 5.9 | 7.45 | 8.53 | 5.56 | 3.79 | 7.84 | 6.56 | 6.23 | 8.25 | 7.08 | 8.82 |
| Net Sales Growth(%) | 0.92 | 20.09 | 15.45 | -6.88 | -34.86 | -6.95 | 49.3 | 28.55 | 1.5 | 20.81 | 51.37 |
| EBIT Growth(%) | -13.47 | 39.89 | 119.36 | -26.68 | -54.9 | -29.31 | 81.53 | 67.84 | 24.22 | 27.78 | 28.35 |
| PAT Growth(%) | -11.13 | 68.7 | 131.78 | -24.08 | -41.56 | -61.61 | 147.9 | 80.86 | 16.28 | 30.52 | 29.15 |
| EPS Growth(%) | -11.13 | 68.7 | 131.78 | -24.08 | -41.56 | -61.61 | 147.9 | 80.86 | 16.28 | 30.52 | 29.14 |
| Debt/Equity(x) | 1.4 | 1.01 | 0.29 | 0.27 | 0.3 | 0.29 | 0.29 | 0.41 | 0.53 | 0.41 | 0.22 |
| Current Ratio(x) | 0.62 | 0.67 | 0.8 | 0.86 | 0.7 | 0.87 | 1.03 | 0.79 | 0.76 | 0.8 | 0.88 |
| Quick Ratio(x) | 0.53 | 0.58 | 0.63 | 0.69 | 0.46 | 0.66 | 0.72 | 0.62 | 0.58 | 0.63 | 0.73 |
| Interest Cover(x) | 2.83 | 4.76 | 14.58 | 11.34 | 4.79 | 2.56 | 5.08 | 9.15 | 5.34 | 5.93 | 6.66 |
| Total Debt/Mcap(x) | 0.66 | 0.28 | 0.05 | 0.1 | 0.3 | 0.17 | 0.18 | 0.23 | 0.2 | 0.17 | 0.06 |
| # | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Promoter | 74.59 | 74.59 | 74.59 | 74.59 | 74.66 | 74.66 | 74.66 | 74.66 | 74.66 | 74.66 |
| FII | 0 | 0 | 0 | 0 | 0 | 0.03 | 0.27 | 0.06 | 0.15 | 0.15 |
| DII | 0.11 | 0.11 | 0.11 | 0.11 | 0.11 | 0.11 | 0.12 | 0.21 | 0.22 | 0.22 |
| Public | 25.3 | 25.3 | 25.3 | 25.3 | 25.23 | 25.2 | 24.94 | 25.06 | 24.97 | 24.96 |
| Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
| # | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Promoter | 2.34 | 2.34 | 2.34 | 4.68 | 4.69 | 4.69 | 4.69 | 4.69 | 4.69 | 4.69 |
| FII | 0 | 0 | 0 | 0 | 0 | 0 | 0.02 | 0 | 0.01 | 0.01 |
| DII | 0 | 0 | 0 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 |
| Public | 0.79 | 0.79 | 0.79 | 1.59 | 1.58 | 1.58 | 1.57 | 1.57 | 1.57 | 1.57 |
| Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 3.14 | 3.14 | 3.14 | 6.28 | 6.28 | 6.28 | 6.28 | 6.28 | 6.28 | 6.28 |
| # | 1 Year | 3 Year | 5 Year | 10 Year |
|---|---|---|---|---|
| Sales CAGR | +51% | +23% | +29% | +11% |
| Operating Profit CAGR | +32% | +28% | +29% | +13% |
| PAT CAGR | +27% | +24% | +53% | +20% |
| Share Price CAGR | +10% | +49% | +39% | +23% |
| ROE Average | +20% | +18% | +16% | +17% |
| ROCE Average | +24% | +21% | +19% | +19% |
| # | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Promoter | 74.59 | 74.59 | 74.59 | 74.59 | 74.66 | 74.66 | 74.66 | 74.66 | 74.66 | 74.66 |
| FII | 0 | 0 | 0 | 0 | 0 | 0.03 | 0.27 | 0.06 | 0.15 | 0.15 |
| DII | 0.11 | 0.11 | 0.11 | 0.11 | 0.11 | 0.11 | 0.12 | 0.21 | 0.22 | 0.22 |
| Public | 25.3 | 25.3 | 25.3 | 25.3 | 25.23 | 25.2 | 24.94 | 25.06 | 24.97 | 24.96 |
| Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
| # | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Promoter | 2.34 | 2.34 | 2.34 | 4.68 | 4.69 | 4.69 | 4.69 | 4.69 | 4.69 | 4.69 |
| FII | 0 | 0 | 0 | 0 | 0 | 0 | 0.02 | 0 | 0.01 | 0.01 |
| DII | 0 | 0 | 0 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 |
| Public | 0.79 | 0.79 | 0.79 | 1.59 | 1.58 | 1.58 | 1.57 | 1.57 | 1.57 | 1.57 |
| Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 3.14 | 3.14 | 3.14 | 6.28 | 6.28 | 6.28 | 6.28 | 6.28 | 6.28 | 6.28 |
* The pros and cons are machine generated.
Our experts help you choose the right stocks based on performance, risk, and growth potential.
Looking to buy unlisted shares or need guidance on the investment process? Our expert Private Equity Advisors are here to assist you with accurate information, real-time pricing, and seamless execution.
Want to sell unlisted shares, liquidate your ESOPs, or understand the step-by-step process of liquidation? Connect with our Buying Team for smooth coordination, quick evaluations, and end-to-end support.
Planning to build or grow your portfolio? For Mutual Fund investments, PMS solutions, tailored portfolio creation, and overall wealth management, our dedicated Wealth Team is ready to guide you.
Your relationship manager will connect with you shortly.